CARDINAL HEALTH INC — Form 10-K
Filed August 11, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 8/100
What the filing says
Cardinal Health filed routine exhibits to its Form 10-K for fiscal year ended June 30, 2026: Exhibit 21.1 lists 150+ majority-owned subsidiaries across multiple jurisdictions; Exhibit 23.1 contains Ernst & Young's consent to audit; Exhibits 31.1–31.2 are SOX 302 certifications by CEO Jason M. Hollar and CFO Aaron E. Alt affirming control and financial reporting accuracy; Exhibit 32.1 is their SOX 906 certification; Exhibit 99.1 restates standard forward-looking-statement disclaimers and risk factors (tariffs, opioid litigation, generic drug pricing, cybersecurity, supply chain, regulatory compliance, EtO emissions). No new material transactions, restructurings, or financial results are disclosed in these exhibits.
Why this rating
Boilerplate 10-K exhibits with standard certifications and risk disclaimers; no operational changes, transactions, or financial impacts disclosed. Routine compliance filing.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.